Pfizer And BioNTech To Provide U.S. Government An Additional 50 Million Pediatric Doses Of COVID-19 Vaccine To Support Further Preparedness For Future Needs Read more
Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic γδT Cell Therapies Addressing Solid Tumors Read more
Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For Treatment Of Hospitalized Severe COVID-19 Patients Read more
MPP and Merck Enter Into License Agreement for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, to Increase Broad Access in Low- and Middle-Income Countries Read more
Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform Read more
Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders Read more
Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious Diseases Read more
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate Read more